Sickle Cell Disease and PregnancySCOB IIINCT07488091
Multi Disciplinary Sickle Cell Disease Obstetrics Care Program in Ghana
A study testing Multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital. in people with Sickle Cell Disease and Pregnancy, run by University of Ghana Medical School at 1 site in Ghana.
Trial summary
The goal of this observational study is to determine the feasibility and effectiveness of initiating a multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- Sickle Cell Disease and Pregnancy
- What is being tested?
- Multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital.
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 198 participants
- Where
- 1 siteGhana
- Study dates
- 22 Jan 2026to 15 Mar 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Pregnant women with a confirmed laboratory diagnosis of sickle cell disease
- Pregnancy confirmed by a pelvic ultrasound scan
- Pregnancy should be 34 weeks' gestation or less
- Pregnant women should be aged 18 - 45 years
- Pregnant women should be attendants at the non-academic hospital
Who cannot join
- All pregnant women with sickle cell disease who do not provide informed consent
- All pregnant women with sickle cell disease who are referred for management of acute complications and hospital admission
- All pregnant women with sickle cell disease who are referred for labor and delivery
- All pregnant women with SCD who plan on delivering outside the non-academic hospital and won't be able to adhere to the follow-up procedures during the puerperium (the first six weeks after childbirth)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Dr. Eugenia Vicky N. K. Asare, Senior Specialist Hematologist, MBChB contact
Ghana1 site, 1 recruiting
- Recruiting
Greater Accra Regional Hospital
Accra
Dr. Kwaku Doffour-Dapaah, Obstetrician Gynaecologist, +233 244986547, kdoffour@gmail.com
About this study
Official title: Multi Disciplinary Sickle Cell Disease Obstetrics Care Program in Ghana: Non-academic vs Academic Hospital (Pilot Study)
The goal of this observational study is to determine the feasibility and effectiveness of initiating a multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital.
The main question it aims to answer is: In a before-and-after study design, we will test the hypothesis that multidisciplinary care for pregnant women with SCD in a non-academic hospital will result in a 50% relative risk reduction in mortality compared to the mortality rate in pregnant women with SCD in the same hospital before the multidisciplinary care.
Participants will be managed using the academic hospital's multidisciplinary sickle cell disease obstetrics protocol adapted for the non-academic hospital
Read the detailed description
Sub-Saharan Africa has a high burden of sickle cell disease (SCD). Approximately 300,000 children are born with SCD in Sub-Saharan Africa yearly (Piel et al. 2013). Ghana is one of the most SCD-burdened countries, with 2% (approximately 18,000) newborns delivered with SCD each year (Ohene-Frempong et al. 2008). Compared with the United States of America and the United Kingdom, 2,400 and 300 newborns, respectively, are born with SCD each year.
Many children with SCD living in low-resource settings, particularly urban areas, are now surviving into childbearing years and adulthood due to general improvements in healthcare. With increasing life expectancy in Africa, pregnancy has become an emerging life-threatening complication in women with sickle cell disease (SCD). In low and middle-income countries (LMICs), the odds ratio of maternal death associated with SCD is 22.81 (95% CI 14.67-35.46) (Boafor et al. 2016). The nearly 23-fold increased odds of death are primarily due to SCD-related severe complications (Boafor et al. 2016). There were no evidence-based guidelines for managing pregnant women with SCD in low-resource settings. To address this, from 2012-2014, the Obstetrics Department at Korle-Bu Teaching Hospital (the flagship academic hospital) in Accra, Ghana, established a dedicated SCD Obstetrics clinic based on guidelines adapted from the American College of Obstetrics and Gynecology. The Institutional maternal mortality for women with SCD over these three years (2012-2014) was approximately 12%.
In January 2015, a multidisciplinary SCD obstetrics team, composed of local and international experts, was established at the flagship academic hospital to provide comprehensive care for this high-risk population. The local team included two obstetricians, three hematologists, two midwives, two laboratory scientists, a pediatrician, and a dual-certified anesthesiologist/ pulmonologist. The team conducted a combined retrospective/ prospective case series of all maternal deaths in women with SCD at Korle-Bu Teaching Hospital (the flagship academic hospital in Ghana) over seven years (2010-2016) (Asare et al. 2018). This retrospective data collection highlighted challenges to delivering improved care. Acute chest syndrome, preceded by acute pain episodes, was the leading cause of death in nearly 87% of women (Asare et al. 2018). In May 2015, the team established a joint obstetrics/hematology clinic, instituted close maternal and fetal monitoring, and implemented clinical guidelines/ protocols (including protocols for antenatal care, labor and delivery, postnatal care, and the management of SCD-related complications). In addition, the multidisciplinary SCD obstetrics team established a weekly communication system to adjudicate the management of challenging cases. These interventions resulted in an 89.1% relative risk reduction in maternal mortality (from 10,791 to 1,176 deaths per 100,000 live births; p=0.007) over 13 months (May 2015 - May 2016) (Asare et al. 2017). Since initiating the multidisciplinary SCD obstetrics program, the investigators have consistently decreased maternal mortality in this cohort by approximately 90% compared to before the team was established (Oppong et al. 2019; Swarray-Deen et al. 2022).
Despite overwhelming evidence of the positive impact of the multidisciplinary SCD obstetrics team, the team is restricted to the flagship academic hospital and faces numerous competing demands. Before the creation of the multidisciplinary SCD obstetrics team at Korle-Bu Teaching Hospital, the care of pregnant women with SCD in Ghana, including the investigators' study site, was obstetrician-led. After 7 years, the intervention has increased reach (the proportion of pregnant women with SCD who have received multidisciplinary SCD obstetric care divided by the total number of eligible pregnant women with SCD receiving care in facilities in the Greater Accra Region) from 0% to 20%. While there is a reduction in the maternal mortality ratio in women with SCD at Korle-Bu Teaching Hospital (the flagship academic hospital), the investigators' current reach of approximately 20% is too small to achieve the public health impact of decreased maternal mortality in this cohort in other parts of the Greater Accra Region, where more than 80% of pregnant women with SCD are seen. To reduce maternal mortality in women with SCD living in Ghana (with 16 regions) and elsewhere, the investigators must have a better implementation and scale-up strategy to increase the reach of multidisciplinary SCD obstetrics care in the Greater Accra Region.
There is an unequal distribution of human resources for health in Ghana (Asamani et al. 2021). Academic hospitals have a more significant proportion of highly trained medical personnel than non-academic hospitals. Conducting research and implementing findings into usual care is far more feasible in academic hospitals because of the availability of trained health personnel and other resources. For equitable translation of "research to practice" to be achieved, non-academic hospitals need to participate in conducting these research studies.
To rapidly translate the findings from the multidisciplinary SCD obstetrics program, the investigators proposed transferring these evidence-based practices from the academic hospital in Accra, with a population density of approximately 1,300 people/Km2, to the non-academic hospital. The non-academic hospital, similar to a city or county hospital in the United States of America for the indigent population, is run under the Ghana Health Service (GHS), under the supervision of the Ministry of Health (MoH), Ghana, and is situated approximately 6.6km South-East and 11 minutes from the academic hospital by road, with a population density of 1,500 people/Km2.
The premise of this feasibility study is that task-shifting and improving the care of pregnant women with SCD in a non-academic hospital with a maternal mortality rate of 7,921 deaths per 100,000 live births (2018-2021) in women with SCD will dramatically reduce maternal mortality in this cohort.
Task shifting is crucial to improving the reach of the care of pregnant women with SCD in Ghana, where approximately 2% of the children with SCD are born each year. The findings of the investigators indicate that multidisciplinary care for pregnant women with SCD in academic centers alone is insufficient to increase the reach for the health care of pregnant women with SCD living in Accra or the rest of Ghana and reduce maternal mortality in this cohort by at least 50%. Training healthcare providers (obstetricians, generalists/physicians, anesthesiologists, and nurses/midwives) already working in the non-academic hospital on the protocols used in the management of pregnant women with SCD (from antenatal care through to postnatal care and during admission for acute events) will be far more efficient and sustainable than total dependence on the multidisciplinary SCD obstetrics program at the academic hospital. As of 2022, there were 15 hematologists available for a population of approximately three million in the Greater Accra Region, and approximately 20 hematologists served approximately 34 million people in Ghana. Given the small number of regional hematologists, training efforts focused on generalists/physicians caring for pregnant women with SCD as part of a multidisciplinary approach to care in a non-academic hospital will reduce the maternal mortality. In addition, several pregnant women with SCD (n=150) from the South-Eastern part of the Greater Accra Region attend the non-academic hospital because of its location and accessibility; hence, maternal mortality can be reduced.
The World Health Organization (WHO) defines task shifting as the rational redistribution of tasks among health workforce teams (World Health Organization, 2007). Specific tasks are moved, where appropriate, from highly qualified health workers with shorter training and fewer qualifications to make more efficient use of available human resources for health (World Health Organization, 2007). In Ghana, like many other resource-constrained settings, there is a shortage of well-trained health workers (Asamani et al. 2018). The WHO estimates 1.1 doctors per 10,000 population in Ghana compared to 26 doctors per 10,000 population in the United States of America (World Health Organization, 2007). Even if Ghana embarks on an emergency training program for hematologists focused on the care of individuals with SCD, it will take at least 5 years to certify a hematologist. Due to the shortage of hematologists, multidisciplinary SCD obstetrics care has been limited to academic sites. Other alternatives are needed to address this shortage of health personnel. Task shifting provides a viable option for improving healthcare by making more efficient use of already available human resources while rapidly expanding the human resource pool and building more sustainable capacity.
This project aims to fill the current research-to-practice gap by creating a multidisciplinary SCD obstetrics program to prevent maternal mortality among women with SCD in a resource-constrained country, using implementation science. As described by Powell, the proposed implementation strategies (Plan, Educate, Restructure, and Quality Management) will be employed within the Consolidated Framework for Implementation Research (Damschroder et al. 2009; King et al. 2017). The Consolidated Framework for Implementation Research (CFIR) presents several constructs that acknowledge the multiple levels of systems needed to implement evidence-based interventions. The investigators will use the CFIR to inform the domains and questions for the needs assessment (semi-structured qualitative interviews) for Aim 1. The focus of the investigators will be on the following: intervention characteristics, individuals involved, inner and outer settings, knowledge and beliefs about the intervention, patient needs and resources, self-efficacy, adaptability, and the implementation climate within the organization's structure. Another area the investigators will focus on is the implementation process to assess whether stakeholder engagement, including the leadership of the non-academic hospital in planning and executing the program, will improve support and eventual sustainability (Aim 2). The project also aims to conduct a Hybrid Type 1 Feasibility Study (Aim 3) to extend the investigators' results on decreasing maternal mortality from an academic hospital to a non-academic hospital setting in Accra, Ghana, where the maternal mortality ratio is 7,921 deaths per 100,000 live births among women with SCD (2018-2021). The investigators will test the hypothesis that a task-shifted non-academic hospital site for pregnant women with SCD will be non-inferior to a multidisciplinary SCD obstetrics program in an academic hospital in Accra, Ghana, in reducing maternal mortality in this cohort.
Approach
To test the hypothesis, the investigators will complete the following specific aims:
- Identify contextual determinants (barriers and facilitators) that influence the adaptability of the evidence-based practice of establishing a multidisciplinary SCD obstetrics team as an intervention in the non-academic hospital, including the implementation process (Years 1-2). The goal of this aim was to better understand current knowledge gaps, the perceptions of healthcare providers and hospital administrators regarding the management of pregnant women with SCD, and capacity-strengthening needs to inform future interventions in the non-academic hospital. The investigators conducted semi-structured qualitative interviews with healthcare providers [nurses/midwives and doctors (obstetricians, generalists/physicians, and anesthesiologists)], pregnant women with SCD, and structured interviews with hospital administrators.
- Build capacity for a multidisciplinary sickle cell disease obstetrics program in a non-academic hospital (Years 3-5). The purpose of this aim was to better describe the implementation experience (what worked/what didn't work; the barriers/facilitators) and how the intervention needs to be adapted going forward. This aim addressed the identified barriers to managing pregnant women with SCD identified in Aim 1 by filling knowledge gaps through education and training. The investigators applied previously established education programs and evidence-based protocols developed by the multidisciplinary SCD obstetrics team at Korle-Bu Teaching Hospital (the flagship academic hospital) for caring for pregnant women with SCD, including obstetricians, generalists/physicians, anesthesiologists, and nurses/midwives, in the non-academic hospital. To guide the application of these established educational programs and evidence-based protocols, the investigators used findings from Aim 1, applying the CFIR framework and focusing mainly on the characteristics of the individuals' domain to address knowledge and beliefs about the "intervention" construct.
- Conduct a Hybrid type 1 feasibility study comparing the effectiveness of a physician-based multidisciplinary sickle cell disease obstetrics program in a non-academic hospital (Years 3-5).
The goal of this aim is to determine the feasibility of initiating a multidisciplinary SCD obstetrics program for women with SCD in a non-academic hospital through 'task-shifting'. In a before-and-after study design, the investigators will test the hypothesis that multidisciplinary care for pregnant women with SCD in a non-academic hospital will result in a 50% relative risk reduction in mortality compared to the mortality rate in pregnant women with SCD in the same hospital before the multidisciplinary care.
Method Study design: A Hybrid type 1 feasibility study Study setting: The Greater Accra Regional Hospital (a non-academic hospital and a regional referral facility) is run under the Ghana Health Service (GHS), under the supervision of the Ministry of Health (MoH), Ghana, and is situated approximately 6.6km South-East and 11 minutes from the academic hospital by road. The non-academic hospital has 420 beds with a 110-bed obstetrics unit, and conducts about 8,500 deliveries per year, of which approximately 150 involve women with SCD. At the non-academic hospital, SCD contributes 1.2% of all deliveries and yet accounts for 7.1% of maternal mortality and is a leading indirect cause of maternal death. The maternal mortality ratio in this cohort is 7,921 deaths per 100,00 live births (2018-2021). At the non-academic hospital, the obstetrics unit runs a daily obstetrics clinic with an average weekly attendance of 250 pregnant women (including approximately 10 pregnant women with SCD). Despite the well-staffed obstetrics unit, the non-academic hospital still refers some challenging and high-risk obstetrics cases (including pregnant women with SCD) to the academic hospital. In the investigators' prior studies, >95% of all the pregnant women approached enrolled in the prospective cohort study.
Sample size determination: At the flagship academic hospital, the multidisciplinary SCD obstetrics care program consistently decreased maternal mortality by approximately 90% compared to the obstetrician-led care approach. The investigators expect that the task-shifted program will attain a significant reduction in maternal mortality, but not to the extent of the multidisciplinary SCD obstetrics care program at the academic hospital. If the baseline maternal mortality is 7,921 deaths per 100,000 live births (2018-2021), the investigators expect that a reduction of approximately 50%, or approximately 3,961 deaths per 100,000 live births, will be a measure of success. The investigators plan to recruit and follow up on 198 pregnant women with SCD attending the non-academic hospital to accomplish this aim. Each year, the investigators plan to recruit and follow up 66 pregnant women with SCD from the non-academic hospital.
Data Analysis Plan:
Categorical variables will be summarized with counts and percentages, and continuous variables will be summarized with the mean and standard deviation, or median and inter-quartile range, depending on the distribution. A one-sample proportion test will be performed to compare the observed proportion of maternal mortality to the current rate. Mortality will be further investigated by examining associations with demographic and clinical covariates.
- Conditions
- Sickle Cell Disease and Pregnancy
- Being tested
- Multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital.
- Keywords
- Maternal Mortality, Sickle Cell Disease, Pregnant women
- Medical subject headings
- Anemia, Sickle Cell, Maternal Death
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital.Other
Pregnant women with sickle cell disease
| Study group | Role | What they receive |
|---|---|---|
| Hybrid type-1 feasibility study | Experimental | Pregnant women meeting the eligibility criteria will be managed using the academic hospital's multidisciplinary sickle cell disease obstetrics protocol adapted for the non-academic hospital Receives: Other: Multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maternal mortality
Maternal mortality in women with sickle cell disease
Measured: Up to 40 weeks for each participant
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Mar 2026
- Study start22 Jan 2026
- Primary completion15 Jan 2028 (estimated)
- Study completion15 Mar 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sickle Cell Disease and PregnancyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Pregnant women with Sickle Cell Disease at 34 weeks or less gestation will be recruited into the study
- Masking
- None (open label)
- Enrolment
- 198 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Ghana Medical School
- Sponsor type
- University, hospital or other
- Collaborators
- Vanderbilt University Medical Center, Fogarty International Center of the National Institute of Health
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07488091
- Sponsor's protocol ID
- 5K43TW012579
- Other IDs
- K43TW012579
- Acronym
- SCOB III
- Status last verified
- Mar 2026
- First submitted
- 16 Feb 2026
- Last updated
- 23 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: IPD data protection concerns and confidentiality
Study at a glance
From the registry record, last updated by the sponsor on 23 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Multi Disciplinary Sickle Cell Disease Obstetrics Care Program in Ghana: Non-academic vs Academic Hospital (Pilot Study)
- ClinicalTrials.gov ID
- NCT07488091
- Acronym / sponsor ID
- SCOB III / 5K43TW012579
- Conditions
- Sickle Cell Disease and Pregnancy
- Keywords
- Maternal Mortality, Sickle Cell Disease, Pregnant women
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 198 participants (estimated)
- Lead sponsor
- University of Ghana Medical SchoolUniversity, hospital or other
- Collaborators
- Vanderbilt University Medical Center, Fogarty International Center of the National Institute of Health
- Study start
- 22 Jan 2026 (actual)
- Primary completion
- 15 Jan 2028 (estimated)
- Study completion
- 15 Mar 2028 (estimated)
- First posted
- 23 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to determine the feasibility and effectiveness of initiating a multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital.
The main question it aims to answer is: In a before-and-after study design, we will test the hypothesis that multidisciplinary care for pregnant women with SCD in a non-academic hospital will result in a 50% relative risk reduction in mortality compared to the mortality rate in pregnant women with SCD in the same hospital before the multidisciplinary care.
Participants will be managed using the academic hospital's multidisciplinary sickle cell disease obstetrics protocol adapted for the non-academic hospital
Detailed description
Sub-Saharan Africa has a high burden of sickle cell disease (SCD). Approximately 300,000 children are born with SCD in Sub-Saharan Africa yearly (Piel et al. 2013). Ghana is one of the most SCD-burdened countries, with 2% (approximately 18,000) newborns delivered with SCD each year (Ohene-Frempong et al. 2008). Compared with the United States of America and the United Kingdom, 2,400 and 300 newborns, respectively, are born with SCD each year.
Many children with SCD living in low-resource settings, particularly urban areas, are now surviving into childbearing years and adulthood due to general improvements in healthcare. With increasing life expectancy in Africa, pregnancy has become an emerging life-threatening complication in women with sickle cell disease (SCD). In low and middle-income countries (LMICs), the odds ratio of maternal death associated with SCD is 22.81 (95% CI 14.67-35.46) (Boafor et al. 2016). The nearly 23-fold increased odds of death are primarily due to SCD-related severe complications (Boafor et al. 2016). There were no evidence-based guidelines for managing pregnant women with SCD in low-resource settings. To address this, from 2012-2014, the Obstetrics Department at Korle-Bu Teaching Hospital (the flagship academic hospital) in Accra, Ghana, established a dedicated SCD Obstetrics clinic based on guidelines adapted from the American College of Obstetrics and Gynecology. The Institutional maternal mortality for women with SCD over these three years (2012-2014) was approximately 12%.
In January 2015, a multidisciplinary SCD obstetrics team, composed of local and international experts, was established at the flagship academic hospital to provide comprehensive care for this high-risk population. The local team included two obstetricians, three hematologists, two midwives, two laboratory scientists, a pediatrician, and a dual-certified anesthesiologist/ pulmonologist. The team conducted a combined retrospective/ prospective case series of all maternal deaths in women with SCD at Korle-Bu Teaching Hospital (the flagship academic hospital in Ghana) over seven years (2010-2016) (Asare et al. 2018). This retrospective data collection highlighted challenges to delivering improved care. Acute chest syndrome, preceded by acute pain episodes, was the leading cause of death in nearly 87% of women (Asare et al. 2018). In May 2015, the team established a joint obstetrics/hematology clinic, instituted close maternal and fetal monitoring, and implemented clinical guidelines/ protocols (including protocols for antenatal care, labor and delivery, postnatal care, and the management of SCD-related complications). In addition, the multidisciplinary SCD obstetrics team established a weekly communication system to adjudicate the management of challenging cases. These interventions resulted in an 89.1% relative risk reduction in maternal mortality (from 10,791 to 1,176 deaths per 100,000 live births; p=0.007) over 13 months (May 2015 - May 2016) (Asare et al. 2017). Since initiating the multidisciplinary SCD obstetrics program, the investigators have consistently decreased maternal mortality in this cohort by approximately 90% compared to before the team was established (Oppong et al. 2019; Swarray-Deen et al. 2022).
Despite overwhelming evidence of the positive impact of the multidisciplinary SCD obstetrics team, the team is restricted to the flagship academic hospital and faces numerous competing demands. Before the creation of the multidisciplinary SCD obstetrics team at Korle-Bu Teaching Hospital, the care of pregnant women with SCD in Ghana, including the investigators' study site, was obstetrician-led. After 7 years, the intervention has increased reach (the proportion of pregnant women with SCD who have received multidisciplinary SCD obstetric care divided by the total number of eligible pregnant women with SCD receiving care in facilities in the Greater Accra Region) from 0% to 20%. While there is a reduction in the maternal mortality ratio in women with SCD at Korle-Bu Teaching Hospital (the flagship academic hospital), the investigators' current reach of approximately 20% is too small to achieve the public health impact of decreased maternal mortality in this cohort in other parts of the Greater Accra Region, where more than 80% of pregnant women with SCD are seen. To reduce maternal mortality in women with SCD living in Ghana (with 16 regions) and elsewhere, the investigators must have a better implementation and scale-up strategy to increase the reach of multidisciplinary SCD obstetrics care in the Greater Accra Region.
There is an unequal distribution of human resources for health in Ghana (Asamani et al. 2021). Academic hospitals have a more significant proportion of highly trained medical personnel than non-academic hospitals. Conducting research and implementing findings into usual care is far more feasible in academic hospitals because of the availability of trained health personnel and other resources. For equitable translation of "research to practice" to be achieved, non-academic hospitals need to participate in conducting these research studies.
To rapidly translate the findings from the multidisciplinary SCD obstetrics program, the investigators proposed transferring these evidence-based practices from the academic hospital in Accra, with a population density of approximately 1,300 people/Km2, to the non-academic hospital. The non-academic hospital, similar to a city or county hospital in the United States of America for the indigent population, is run under the Ghana Health Service (GHS), under the supervision of the Ministry of Health (MoH), Ghana, and is situated approximately 6.6km South-East and 11 minutes from the academic hospital by road, with a population density of 1,500 people/Km2.
The premise of this feasibility study is that task-shifting and improving the care of pregnant women with SCD in a non-academic hospital with a maternal mortality rate of 7,921 deaths per 100,000 live births (2018-2021) in women with SCD will dramatically reduce maternal mortality in this cohort.
Task shifting is crucial to improving the reach of the care of pregnant women with SCD in Ghana, where approximately 2% of the children with SCD are born each year. The findings of the investigators indicate that multidisciplinary care for pregnant women with SCD in academic centers alone is insufficient to increase the reach for the health care of pregnant women with SCD living in Accra or the rest of Ghana and reduce maternal mortality in this cohort by at least 50%. Training healthcare providers (obstetricians, generalists/physicians, anesthesiologists, and nurses/midwives) already working in the non-academic hospital on the protocols used in the management of pregnant women with SCD (from antenatal care through to postnatal care and during admission for acute events) will be far more efficient and sustainable than total dependence on the multidisciplinary SCD obstetrics program at the academic hospital. As of 2022, there were 15 hematologists available for a population of approximately three million in the Greater Accra Region, and approximately 20 hematologists served approximately 34 million people in Ghana. Given the small number of regional hematologists, training efforts focused on generalists/physicians caring for pregnant women with SCD as part of a multidisciplinary approach to care in a non-academic hospital will reduce the maternal mortality. In addition, several pregnant women with SCD (n=150) from the South-Eastern part of the Greater Accra Region attend the non-academic hospital because of its location and accessibility; hence, maternal mortality can be reduced.
The World Health Organization (WHO) defines task shifting as the rational redistribution of tasks among health workforce teams (World Health Organization, 2007). Specific tasks are moved, where appropriate, from highly qualified health workers with shorter training and fewer qualifications to make more efficient use of available human resources for health (World Health Organization, 2007). In Ghana, like many other resource-constrained settings, there is a shortage of well-trained health workers (Asamani et al. 2018). The WHO estimates 1.1 doctors per 10,000 population in Ghana compared to 26 doctors per 10,000 population in the United States of America (World Health Organization, 2007). Even if Ghana embarks on an emergency training program for hematologists focused on the care of individuals with SCD, it will take at least 5 years to certify a hematologist. Due to the shortage of hematologists, multidisciplinary SCD obstetrics care has been limited to academic sites. Other alternatives are needed to address this shortage of health personnel. Task shifting provides a viable option for improving healthcare by making more efficient use of already available human resources while rapidly expanding the human resource pool and building more sustainable capacity.
This project aims to fill the current research-to-practice gap by creating a multidisciplinary SCD obstetrics program to prevent maternal mortality among women with SCD in a resource-constrained country, using implementation science. As described by Powell, the proposed implementation strategies (Plan, Educate, Restructure, and Quality Management) will be employed within the Consolidated Framework for Implementation Research (Damschroder et al. 2009; King et al. 2017). The Consolidated Framework for Implementation Research (CFIR) presents several constructs that acknowledge the multiple levels of systems needed to implement evidence-based interventions. The investigators will use the CFIR to inform the domains and questions for the needs assessment (semi-structured qualitative interviews) for Aim 1. The focus of the investigators will be on the following: intervention characteristics, individuals involved, inner and outer settings, knowledge and beliefs about the intervention, patient needs and resources, self-efficacy, adaptability, and the implementation climate within the organization's structure. Another area the investigators will focus on is the implementation process to assess whether stakeholder engagement, including the leadership of the non-academic hospital in planning and executing the program, will improve support and eventual sustainability (Aim 2). The project also aims to conduct a Hybrid Type 1 Feasibility Study (Aim 3) to extend the investigators' results on decreasing maternal mortality from an academic hospital to a non-academic hospital setting in Accra, Ghana, where the maternal mortality ratio is 7,921 deaths per 100,000 live births among women with SCD (2018-2021). The investigators will test the hypothesis that a task-shifted non-academic hospital site for pregnant women with SCD will be non-inferior to a multidisciplinary SCD obstetrics program in an academic hospital in Accra, Ghana, in reducing maternal mortality in this cohort.
Approach
To test the hypothesis, the investigators will complete the following specific aims:
- Identify contextual determinants (barriers and facilitators) that influence the adaptability of the evidence-based practice of establishing a multidisciplinary SCD obstetrics team as an intervention in the non-academic hospital, including the implementation process (Years 1-2). The goal of this aim was to better understand current knowledge gaps, the perceptions of healthcare providers and hospital administrators regarding the management of pregnant women with SCD, and capacity-strengthening needs to inform future interventions in the non-academic hospital. The investigators conducted semi-structured qualitative interviews with healthcare providers [nurses/midwives and doctors (obstetricians, generalists/physicians, and anesthesiologists)], pregnant women with SCD, and structured interviews with hospital administrators.
- Build capacity for a multidisciplinary sickle cell disease obstetrics program in a non-academic hospital (Years 3-5). The purpose of this aim was to better describe the implementation experience (what worked/what didn't work; the barriers/facilitators) and how the intervention needs to be adapted going forward. This aim addressed the identified barriers to managing pregnant women with SCD identified in Aim 1 by filling knowledge gaps through education and training. The investigators applied previously established education programs and evidence-based protocols developed by the multidisciplinary SCD obstetrics team at Korle-Bu Teaching Hospital (the flagship academic hospital) for caring for pregnant women with SCD, including obstetricians, generalists/physicians, anesthesiologists, and nurses/midwives, in the non-academic hospital. To guide the application of these established educational programs and evidence-based protocols, the investigators used findings from Aim 1, applying the CFIR framework and focusing mainly on the characteristics of the individuals' domain to address knowledge and beliefs about the "intervention" construct.
- Conduct a Hybrid type 1 feasibility study comparing the effectiveness of a physician-based multidisciplinary sickle cell disease obstetrics program in a non-academic hospital (Years 3-5).
The goal of this aim is to determine the feasibility of initiating a multidisciplinary SCD obstetrics program for women with SCD in a non-academic hospital through 'task-shifting'. In a before-and-after study design, the investigators will test the hypothesis that multidisciplinary care for pregnant women with SCD in a non-academic hospital will result in a 50% relative risk reduction in mortality compared to the mortality rate in pregnant women with SCD in the same hospital before the multidisciplinary care.
Method Study design: A Hybrid type 1 feasibility study Study setting: The Greater Accra Regional Hospital (a non-academic hospital and a regional referral facility) is run under the Ghana Health Service (GHS), under the supervision of the Ministry of Health (MoH), Ghana, and is situated approximately 6.6km South-East and 11 minutes from the academic hospital by road. The non-academic hospital has 420 beds with a 110-bed obstetrics unit, and conducts about 8,500 deliveries per year, of which approximately 150 involve women with SCD. At the non-academic hospital, SCD contributes 1.2% of all deliveries and yet accounts for 7.1% of maternal mortality and is a leading indirect cause of maternal death. The maternal mortality ratio in this cohort is 7,921 deaths per 100,00 live births (2018-2021). At the non-academic hospital, the obstetrics unit runs a daily obstetrics clinic with an average weekly attendance of 250 pregnant women (including approximately 10 pregnant women with SCD). Despite the well-staffed obstetrics unit, the non-academic hospital still refers some challenging and high-risk obstetrics cases (including pregnant women with SCD) to the academic hospital. In the investigators' prior studies, >95% of all the pregnant women approached enrolled in the prospective cohort study.
Sample size determination: At the flagship academic hospital, the multidisciplinary SCD obstetrics care program consistently decreased maternal mortality by approximately 90% compared to the obstetrician-led care approach. The investigators expect that the task-shifted program will attain a significant reduction in maternal mortality, but not to the extent of the multidisciplinary SCD obstetrics care program at the academic hospital. If the baseline maternal mortality is 7,921 deaths per 100,000 live births (2018-2021), the investigators expect that a reduction of approximately 50%, or approximately 3,961 deaths per 100,000 live births, will be a measure of success. The investigators plan to recruit and follow up on 198 pregnant women with SCD attending the non-academic hospital to accomplish this aim. Each year, the investigators plan to recruit and follow up 66 pregnant women with SCD from the non-academic hospital.
Data Analysis Plan:
Categorical variables will be summarized with counts and percentages, and continuous variables will be summarized with the mean and standard deviation, or median and inter-quartile range, depending on the distribution. A one-sample proportion test will be performed to compare the observed proportion of maternal mortality to the current rate. Mortality will be further investigated by examining associations with demographic and clinical covariates.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Pregnant women with Sickle Cell Disease at 34 weeks or less gestation will be recruited into the study
| Arm | Type | Receives |
|---|---|---|
| Hybrid type-1 feasibility study | Experimental | Other: Multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital.Pregnant women meeting the eligibility criteria will be managed using the academic hospital's multidisciplinary sickle cell disease obstetrics protocol adapted for the non-academic hospital |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Pregnant women with a confirmed laboratory diagnosis of sickle cell disease
- Pregnancy confirmed by a pelvic ultrasound scan
- Pregnancy should be 34 weeks' gestation or less
- Pregnant women should be aged 18 - 45 years
- Pregnant women should be attendants at the non-academic hospital
Key exclusion criteria (4 listed)
- All pregnant women with sickle cell disease who do not provide informed consent
- All pregnant women with sickle cell disease who are referred for management of acute complications and hospital admission
- All pregnant women with sickle cell disease who are referred for labor and delivery
- All pregnant women with SCD who plan on delivering outside the non-academic hospital and won't be able to adhere to the follow-up procedures during the puerperium (the first six weeks after childbirth)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital.Pregnant women with sickle cell disease | Other | Hybrid type-1 feasibility study |
Primary outcome
Maternal mortality
Time frame: Up to 40 weeks for each participant
Maternal mortality in women with sickle cell disease
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Mar 2026.
- Individual participant dataSharing planned: No. IPD data protection concerns and confidentiality
Related trials for Sickle Cell Disease and Pregnancy
Not yet recruitingObservational study
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)
Antiphospholipid (aPL)-Positive, Rheumatic Arthritis
RecruitingObservational study
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including, Sickle Cell Disease
RecruitingPhase 2
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Sickle Cell Disease Vaso-occlusive Crisis
Active, not recruitingObservational study
Cooperative Assessment of Late Effects for SCD Curative Therapies
Sickle Cell Disease, Pulmonary Disease
RecruitingObservational study
Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System
Cardiac Diseases, Sickle Cell Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Dr. Eugenia Vicky N. K. Asare, Senior Specialist Hematologist, MBChB contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital. in people with Sickle Cell Disease and Pregnancy, run by University of Ghana Medical School at 1 site in Ghana.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 23 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Ghana. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Dr. Eugenia Vicky N. K. Asare, Senior Specialist Hematologist, MBChB (+233 542354386 / 233 302660762, evnkasare@ug.edu.gh), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maternal mortality (time frame: Up to 40 weeks for each participant). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2026.